LBPH

Longboard Pharmaceuticals, Inc.

21.62 USD
-0.56 (-2.52%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Longboard Pharmaceuticals, Inc. stock is up 1.79% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 3 March’s closed higher than February. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Feb 19:08 16 Aug, 2024 22.50 CALL 60 6

About Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc. focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies.